CS logo
small CS logo
Langley Porter Psychiatric Institute

San Francisco, California, United States
Psychiatric hospital in San Francisco, California
401 Parnassus Ave, San Francisco, CA 94143

About Langley Porter Psychiatric Institute


The Langley Porter Psychiatric Institute is a psychiatric teaching hospital, part of the Psychiatry Department at the University of California, San Francisco. It is located at 401 Parnassus Avenue at Hillway Avenue on the Parnassus campus of UCSF.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Langley Porter Psychiatric Institute


During the past decade, Langley Porter Psychiatric Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Langley Porter Psychiatric Institute" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator, "American Cancer Society, Inc." with 1 trials as a collaborator, "Leon J. Epstein Endowment" with 1 trials as a collaborator, "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Langley Porter Psychiatric Institute


According to Clinical.Site data, the most researched conditions in "Langley Porter Psychiatric Institute" are "Methamphetamine Dependence" (3 trials), "Smoking Cessation" (3 trials), "Tobacco Use Cessation" (2 trials), "Tobacco Use Disorder" (2 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Langley Porter Psychiatric Institute" in a lesser frequency.

Clinical Trials Intervention Types at Langley Porter Psychiatric Institute


Most popular intervention types in "Langley Porter Psychiatric Institute" are "Behavioral" (7 trials), "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Expert System Only" (2 trials), "Lobeline" (2 trials), "Brief Intervention" (1 trials), "Enhanced Expert System" (1 trials) and "Expert System" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Langley Porter Psychiatric Institute


The vast majority of trials in "Langley Porter Psychiatric Institute" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Langley Porter Psychiatric Institute


Currently, there are NaN active trials in "Langley Porter Psychiatric Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Langley Porter Psychiatric Institute, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Langley Porter Psychiatric Institute, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".